HER2-positive breast cancer
German Breast group · San Raffaele University of Rome
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,102
total citations
- FWCI
- 22.80
- Percentile
- 100%
- References
- 97
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Pertuzumab
- Trastuzumab
- Medicine
- Breast cancer
- Oncology
- Internal medicine
- Adjuvant
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.